Beauty Farm Medical & Health Industry, Inc. (HK:2373)
:2373
Want to see HK:2373 full AI Analyst Report?
2373 Stock Chart & Stats
HK$26.36
HK$0.14(0.75%)
At close: 4:00 PM EST
HK$26.36
HK$0.14(0.75%)
Day’s Range― - ―
52-Week RangeHK$16.86 - HK$41.60
Previous CloseN/A
Volume52.00K
Average Volume (3M)539.77K
Market Cap
HK$4.97B
Enterprise ValueHK$4.44B
Total Cash (Recent Filing)HK$2.57B
Total Debt (Recent Filing)HK$1.29B
Price to Earnings (P/E)17.8
Beta0.42
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.97%
Share Statistics
EPS (TTM)1.38
Shares Outstanding251,593,720
10 Day Avg. Volume911,428
30 Day Avg. Volume539,766
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)5.54
Price to Sales (P/S)1.89
P/FCF Ratio6.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$31.31Price Target Upside18.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)1.8
Revenue Forecast (FY)HK$4.00B
Bulls Say, Bears Say
Bulls Say
Revenue & Margin ExpansionA clear step-up in revenue alongside a rising net margin indicates the business is converting sales into profit more efficiently. This structural improvement suggests scalable demand, better pricing or cost control, and a stronger baseline for durable earnings and reinvestment over the next 2–6 months.
Cash Generation AbilityImproving operating and free cash flow demonstrates the company is converting higher revenue into real cash, supporting reinvestment, dividend capacity, and debt servicing. Strong cash conversion is a durable structural strength that underpins financial flexibility and long-term strategy execution.
Sustained Earnings GrowthDouble-digit revenue growth together with materially higher EPS growth signals operational leverage and improving profitability per share. This indicates the business model is scaling and generating expanding shareholder value, supporting stable fundamentals over the medium term.
Bears Say
Rising LeverageA sharp increase in leverage materially raises financial risk, limits strategic flexibility, and increases exposure to interest costs and refinancing risk. Higher debt levels can constrain capital allocation, reduce resilience to downturns, and elevate the chance of covenant or liquidity stress within months.
Cash-flow Quality UncertaintyAlthough headline cash generation rose, negative FCF growth and missing/zeroed coverage metrics undermine confidence in consistency. This raises the risk that cash available for debt service, dividends, or reinvestment may be less reliable, complicating long-term planning and credit profiles.
Earnings Volatility HistoryHistorical swings in margins and a prior revenue decline suggest earnings are not perfectly stable and may be sensitive to operational or market cycles. This variability reduces predictability of future profits and complicates forecasting, increasing risk for investors focused on consistent cash returns.
Beauty Farm Medical & Health Industry, Inc. News
2373 FAQ
What was Beauty Farm Medical & Health Industry, Inc.’s price range in the past 12 months?
Beauty Farm Medical & Health Industry, Inc. lowest stock price was HK$16.86 and its highest was HK$41.60 in the past 12 months.
What is Beauty Farm Medical & Health Industry, Inc.’s market cap?
Beauty Farm Medical & Health Industry, Inc.’s market cap is HK$4.97B.
When is Beauty Farm Medical & Health Industry, Inc.’s upcoming earnings report date?
Beauty Farm Medical & Health Industry, Inc.’s upcoming earnings report date is Sep 01, 2026 which is in 102 days.
How were Beauty Farm Medical & Health Industry, Inc.’s earnings last quarter?
Beauty Farm Medical & Health Industry, Inc. released its earnings results on Mar 27, 2026. The company reported HK$0.752 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.752.
Is Beauty Farm Medical & Health Industry, Inc. overvalued?
According to Wall Street analysts Beauty Farm Medical & Health Industry, Inc.’s price is currently Undervalued.
Does Beauty Farm Medical & Health Industry, Inc. pay dividends?
Beauty Farm Medical & Health Industry, Inc. pays a Annually dividend of HK$0.52 which represents an annual dividend yield of 1.97%. See more information on Beauty Farm Medical & Health Industry, Inc. dividends here
What is Beauty Farm Medical & Health Industry, Inc.’s EPS estimate?
Beauty Farm Medical & Health Industry, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beauty Farm Medical & Health Industry, Inc. have?
Beauty Farm Medical & Health Industry, Inc. has 251,593,720 shares outstanding.
What happened to Beauty Farm Medical & Health Industry, Inc.’s price movement after its last earnings report?
Beauty Farm Medical & Health Industry, Inc. reported an EPS of HK$0.752 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.147%.
Which hedge fund is a major shareholder of Beauty Farm Medical & Health Industry, Inc.?
Currently, no hedge funds are holding shares in HK:2373
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beauty Farm Medical & Health Industry, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
HK$31.31 (18.79% Upside)
HK$31.31 (18.79% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
96.26%
12-Months-Change
Fundamentals
Return on Equity
33.08%
Trailing 12-Months
Asset Growth
23.50%
Trailing 12-Months
Company Description
Beauty Farm Medical & Health Industry, Inc.
Beauty Farm Medical and Health Industry Inc. provides beauty and health management services in the People's Republic of China It offers traditional beauty services; aesthetic medical services, including non-surgical aesthetic medical services, such as energy-based services and injection services, as well as surgical aesthetic medical services; and subhealth assessment and intervention services. As of June 30, 2022, the company operated 352 stores, including 177 direct stores and 175 franchised stores under the BeautyFarm, Palaispa, Neology, and CellCare brand names. The company was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.
2373 Stock 12 Month Forecast
Average Price Target
HK$31.31
▲(18.79% Upside)
Technical Analysis
Rici Healthcare Holdings Ltd.
―
Jinxin Fertility Group Ltd.
―
Raily Aesthetic Medicine International Holdings Limited
―
Gushengtang Holdings Limited
―
Hygeia Healthcare Holdings Co., Ltd.
―
Options Prices
Currently, No data available
---